Rosol Michael Stanley 4
4 · NAVIDEA BIOPHARMACEUTICALS, INC. · Filed Dec 29, 2021
Insider Transaction Report
Form 4
Rosol Michael Stanley
Chief Medical Officer
Transactions
- Award
Stock Option
2021-12-27$0.00/sh+100,000$100→ 100,000 totalExercise: $1.08Exp: 2031-12-27→ Common Stock (100,000 underlying)
Footnotes (1)
- [F1]Stock options granted pursuant to Issuer's 2014 Amended and Restated Stock Incentive Plan, which vest as to one-fourth on each of the first four anniversaries of the date of grant.